Detalles de la búsqueda
1.
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL).
Jpn J Clin Oncol;
2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594880
2.
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumors.
Invest New Drugs;
40(5): 1011-1020, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35932386
3.
Programmed cell death ligand 1 measurement study in granulocyte colony-stimulating factor-producing lung cancer: an observational study.
BMC Cancer;
22(1): 977, 2022 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100844
4.
Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant data.
BMC Pulm Med;
22(1): 31, 2022 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35000608
5.
Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913.
Invest New Drugs;
39(1): 202-209, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32803700
6.
Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutations.
Invest New Drugs;
37(6): 1207-1217, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30790152
7.
Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
BMC Cancer;
18(1): 1012, 2018 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30348116
8.
Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.
BMC Cancer;
17(1): 377, 2017 05 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28549414
9.
A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201).
Jpn J Clin Oncol;
45(1): 115-8, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25332420
10.
A prospective study of shortened vitamin supplementation prior to cisplatin-pemetrexed therapy for non-small cell lung cancer.
Oncologist;
19(11): 1194-9, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25260366
11.
A feasibility study of carboplatin plus irinotecan treatment for elderly patients with extensive disease small-cell lung cancer.
Jpn J Clin Oncol;
44(2): 116-21, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24338555
12.
Patterns and Incidence of Pneumonitis and Initial Treatment Outcomes with Durvalumab Consolidation Therapy after Radical Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer.
Cancers (Basel);
16(6)2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38539497
13.
A Phase â ¡ Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung Cancer: TORG2241 (UBE-Q).
Clin Lung Cancer;
25(1): 85-90, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37981477
14.
Association of PD-L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR-mutated NSCLC.
Cancer Med;
12(17): 17788-17797, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37548381
15.
Multicenter, single-arm phase II study of modified carboplatin/nab-paclitaxel in untreated performance status 2 patients with advanced non-small cell lung cancer: TORG1426.
Transl Cancer Res;
12(4): 873-886, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37180670
16.
Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial.
Lung Cancer;
181: 107195, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156212
17.
Entrectinib Response to ROS1-Fusion-Positive Non-Small-Cell Lung Cancer That Progressed on Crizotinib with Leptomeningeal Metastasis: A Case Report.
Case Rep Oncol;
16(1): 1558-1567, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38089732
18.
Acute pancreatitis or severe increase in pancreatic enzyme levels following remdesivir administration in COVID-19 patients: an observational study.
Sci Rep;
12(1): 5323, 2022 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35351942
19.
A case of pulmonary tumor thrombotic microangiopathy following lymphedema on the lower extremities.
Respir Med Case Rep;
37: 101631, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35342709
20.
A case of slowly progressive malignant pericardial mesothelioma suggesting the involvement of BAP1 loss.
Respirol Case Rep;
10(9): e01004, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35950141